977 related articles for article (PubMed ID: 17299012)
21. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ
J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720
[TBL] [Abstract][Full Text] [Related]
22. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B
Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695
[TBL] [Abstract][Full Text] [Related]
23. Optimizing therapy for MRSA pneumonia.
Skrupky LP; Micek ST; Kollef MH
Semin Respir Crit Care Med; 2007 Dec; 28(6):615-23. PubMed ID: 18095225
[TBL] [Abstract][Full Text] [Related]
24. Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid.
Kessler AT; Kourtis AP
Infection; 2007 Jun; 35(4):271-4. PubMed ID: 17646913
[TBL] [Abstract][Full Text] [Related]
25. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
Itani KM; Weigelt J; Li JZ; Duttagupta S
Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514
[TBL] [Abstract][Full Text] [Related]
26. Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children.
Kaplan SL; Afghani B; Lopez P; Wu E; Fleishaker D; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S178-85. PubMed ID: 14520144
[TBL] [Abstract][Full Text] [Related]
27. [Lipopeptides and oxazolidinones--novel antibiotics in MRSA infection treatment].
Pangercić A; Bukovski-Simonoski S; Barsić B
Lijec Vjesn; 2010; 132 Suppl 1():11-3. PubMed ID: 20715711
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of linezolid versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus discitis: a controlled animal model.
Conaughty JM; Chen J; Martinez OV; Chiappetta G; Brookfield KF; Eismont FJ
Spine (Phila Pa 1976); 2006 Oct; 31(22):E830-2. PubMed ID: 17047530
[TBL] [Abstract][Full Text] [Related]
29. Treatment of infections due to resistant Staphylococcus aureus.
Anstead GM; Cadena J; Javeri H
Methods Mol Biol; 2014; 1085():259-309. PubMed ID: 24085702
[TBL] [Abstract][Full Text] [Related]
30. New therapy options for MRSA with respiratory infection/pneumonia.
Ramirez P; Fernández-Barat L; Torres A
Curr Opin Infect Dis; 2012 Apr; 25(2):159-65. PubMed ID: 22248980
[TBL] [Abstract][Full Text] [Related]
31. New treatments for methicillin-resistant Staphylococcus aureus.
Stryjewski ME; Corey GR
Curr Opin Crit Care; 2009 Oct; 15(5):403-12. PubMed ID: 19561492
[TBL] [Abstract][Full Text] [Related]
32. Methicillin-resistant Staphylococcus aureus pneumonia after thoracic surgery: successful treatment with linezolid after failed vancomycin therapy.
Salerno D; Vahid B; Marik PE
Ann Thorac Surg; 2007 May; 83(5):1888-91. PubMed ID: 17462428
[TBL] [Abstract][Full Text] [Related]
33. Methicillin-resistant Staphylococcus aureus: the superbug.
Ippolito G; Leone S; Lauria FN; Nicastri E; Wenzel RP
Int J Infect Dis; 2010 Oct; 14 Suppl 4():S7-11. PubMed ID: 20851011
[TBL] [Abstract][Full Text] [Related]
34. Pneumonia caused by methicillin-resistant Staphylococcus aureus.
Rubinstein E; Kollef MH; Nathwani D
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S378-85. PubMed ID: 18462093
[TBL] [Abstract][Full Text] [Related]
35. Treatment of hospital-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus.
Ferrara AM
Int J Antimicrob Agents; 2007 Jul; 30(1):19-24. PubMed ID: 17475449
[TBL] [Abstract][Full Text] [Related]
36. Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia.
Scheetz MH; Wunderink RG; Postelnick MJ; Noskin GA
Pharmacotherapy; 2006 Apr; 26(4):539-50. PubMed ID: 16553514
[TBL] [Abstract][Full Text] [Related]
37. [New treatment option for gram-positive infections in critically ill patients - overview over linezolid].
Krueger WA; Unertl KE
Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Apr; 37(4):199-204. PubMed ID: 11967745
[TBL] [Abstract][Full Text] [Related]
38. Management of methicillin-resistant Staphylococcus aureus pneumonia.
Luna CM; Boyeras Navarro ID
Curr Opin Infect Dis; 2010 Apr; 23(2):178-84. PubMed ID: 20075728
[TBL] [Abstract][Full Text] [Related]
39. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.
Rubinstein E; Cammarata S; Oliphant T; Wunderink R;
Clin Infect Dis; 2001 Feb; 32(3):402-12. PubMed ID: 11170948
[TBL] [Abstract][Full Text] [Related]
40. Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses.
Powers JH; Ross DB; Lin D; Soreth J
Chest; 2004 Jul; 126(1):314-5; author reply 315-6. PubMed ID: 15249482
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
